Site Map
Posts
- Category: Wp Feeds (continued)
- ACP Calls for Colon Cancer Screening at 50 (CME/CE)
- ACP Calls on Government to Curb Drug Prices
- ACP Highlights 2014's Top Studies
- ACP Opposes 'Mass Deportation' Proposals on Health Grounds
- ACP: Less Screening Is Better in Most Adults (CME/CE)
- ACR: Long-Term Biologic Use in RA Cuts MI, Cancer Risk (CME/CE)
- ACR: Long-Term Biologic Use in RA Cuts MI, Cancer Risk (CME/CE)
- Active Faith Predicts Survival After Liver Transplant (CME/CE)
- Acupuncture Plus Electricity Helps in Endoscopy
- Acupuncture Points Useful in Diabetes Control? (CME/CE)
- ADA: Insulin Does Not Hike Cancer Risk (CME/CE)
- Adjuvant Oxaliplatin Confers Survival Benefit in Colon Ca (CME/CE)
- Adult Travelers Bypass MMR, Hep A Shots (CME/CE)
- Adults with CF Need Close Colon Cancer Screening (CME/CE)
- Advanced Colorectal Cancer Drug Extends Survival, Maker Says
- Advanced Fatty Liver Rising in Teens (CME/CE)
- Adverse Effects of GI Cancer Therapy Long-Lasting
- African, European Kids Have Different Gut Bugs (CME/CE)
- After the Cancer the Worry Remains (CME/CE)
- AGA Urges Cautious Management of Pancreatic Cysts (CME/CE)
- Age Plays Strong Role in H. Pylori Recurrence (CME/CE)
- Agent Adds 2 Months to Gastric Ca Survival
- Agent Promising for Refractory Colon Cancer (CME/CE)
- Aggressive Liver Cancer Tracked to Genetic Driver (CME/CE)
- Aging, Better Therapies Boost Cancer Survivor Numbers (CME/CE)
- AHA: HF Tied to Higher Risk for Fatal Cancer
- AHA: PPI-Aspirin Pill Eases GI Ulcers in Heart Patients (CME/CE)
- AHIP Blasts 'Unsustainable' Drug Costs
- AI and Breast Cancer Screening; Cancer After Treatment for Sickle Cell
- AIDS Science Meeting Returns to Paris
- Airborne Hydrocarbons: Liver Cancer Cause?
- Alarm Fatigue Has a Potential Real-Life Consequence
- Alcohol Use Before Liver Tx Key to Use Afterward (CME/CE, with audio)
- Alcohol-Inflamed Livers Benefit from Early Transplant (CME/CE)
- Alcoholic Liver Disease May Not Lead to Cancer (CME/CE)
- All-Oral HCV Regimen Works in 9 Out of 10
- All-Oral Regimens Work in HCV (CME/CE)
- All-Oral Treatment Suppresses Hep C in HIV Patients (CME/CE)
- All-Oral Triple Combo Has High HCV Cure Rate (CME/CE)
- All-Oral Tx Feasible in HCV With Advanced Liver Disease (CME/CE)
- Alopecia on the Rise After COVID, Study Suggests
- AMA Adopts Policy on Med Student Mental Health Access
- AMA Clamps Down on MOC, But Punts on Gun Regs
- AMA Launches Company in Silicon Valley
- AMA Members: Focus on Regulations, Not Legislation
- AMA Pans 'High Stakes' Exams
- AMA President: On the Record
- AMA Wants Ban on DTC Advertising
- Americans' Rx Drug Spending Tops $300 Billion
- Anal Cancer Rates Continue to Rise (CME/CE)
